{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:57:52Z","timestamp":1778525872415,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Mary R. Gibson Foundation"},{"name":"Mabel and Everett Hinkson Memorial Fund"},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["DK110023"],"award-info":[{"award-number":["DK110023"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/ckj\/sfy010","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T15:10:42Z","timestamp":1516979442000},"page":"791-796","source":"Crossref","is-referenced-by-count":4,"title":["Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8562-1054","authenticated-orcid":false,"given":"Mini","family":"Michael","sequence":"first","affiliation":[{"name":"Texas Children\u2019s Hospital, Houston, TX, USA"},{"name":"Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Turner","sequence":"additional","affiliation":[{"name":"Rice University, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Elenberg","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital, Houston, TX, USA"},{"name":"Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda G","family":"Shaffer","sequence":"additional","affiliation":[{"name":"Dell\u2019s Children\u2019s Hospital, Austin, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Teruya","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital, Houston, TX, USA"},{"name":"Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Arar","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiu-Ki","family":"Hui","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital, Houston, TX, USA"},{"name":"Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"Smith","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories, University of Iowa Carver College of Medicine, Iowa City, IA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Moake","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, TX, USA"},{"name":"Rice University, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B1","first-page":"8","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B2","first-page":"3268","article-title":"Control of the amplification convertase of complement by the plasma protein beta1H","volume":"73","author":"Weiler","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B3","first-page":"I15","article-title":"Discrimination between host and pathogens by the complement system","volume":"26(Suppl 8)","author":"Pangburn","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B4","first-page":"4742","article-title":"Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement","volume":"164","author":"Pangburn","year":"2000","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B5","first-page":"387","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B6","first-page":"60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B7","first-page":"E1445","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B8","first-page":"1516","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B9","first-page":"e59372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B10","first-page":"509","article-title":"Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes","volume":"29","author":"Turner","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B11","first-page":"393","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B12","first-page":"27","article-title":"High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome","volume":"82","author":"Coppo","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B13","first-page":"380","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B14","first-page":"e0152164","article-title":"Complement factor H-related protein 3 serum levels are low compared to factor H and mainly determined by gene copy number variation in CFHR3","volume":"11","author":"Pouw","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B15","first-page":"1034","article-title":"Complement dysregulation and disease: from genes and proteins to diagnostics and drugs","volume":"217","author":"de Cordoba","year":"2012","journal-title":"Immunobiology"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B16","first-page":"531","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B17","first-page":"467","article-title":"Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children","volume":"19","author":"Kavakli","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B18","first-page":"60","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B19","first-page":"2151","article-title":"Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency","volume":"57","author":"Li","year":"2017","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B20","first-page":"379","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B21","first-page":"170","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B22","first-page":"620","article-title":"FHR3 blocks C3d-mediated coactivation of human B cells","volume":"197","author":"Buhlmann","year":"2016","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B23","first-page":"451","article-title":"Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome","volume":"30","author":"Khandelwal","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B24","first-page":"1151","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B25","first-page":"100","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B26","first-page":"302","article-title":"Regulation of Weibel-Palade body exocytosis","volume":"15","author":"Lowenstein","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B27","first-page":"14","article-title":"Activity of von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates","volume":"67","author":"Strauss","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B28","first-page":"1707","article-title":"Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo","volume":"4","author":"Shelat","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B29","first-page":"209","article-title":"ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura \u2013 current perspectives and new treatment strategies","volume":"9","author":"Tersteeg","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"key\n\t\t\t\t2018120302541783900_sfy010-B30","first-page":"942","article-title":"Pathogenicity of Anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/11\/6\/791\/26912326\/sfy010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T02:54:31Z","timestamp":1543805671000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/11\/6\/791\/4924409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy010","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,3,7]]}}}